Positive feedback loop between vision-related anxiety and self-reported visual difficulty
Carregando...
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
TAYLOR & FRANCIS INC
Autores
POPOVA, Lilia T.
ABUZAITOUN, Rebhi O.
FRESCO, David M.
ANDREWS, Chris A.
MUSCH, David C.
EHRLICH, Joshua R.
JAYASUNDERA, K. Thiran
Citação
OPHTHALMIC GENETICS, v.44, n.4, p.327-333, 2023
Resumo
BackgroundPatients with Inherited Retinal Diseases typically experience progressive, irreversible vision loss resulting in low vision and blindness. As a result, these patients are at high risk for vision-related disability and psychological distress, including depression and anxiety. Historically, the relationship between self-reported visual difficulty (encompassing metrics of vision-related disability and quality of life, among others) and vision-related anxiety has been regarded as an association and not a causal relationship. As a result, there are limited interventions available that address vision-related anxiety and the psychological and behavioral components of self-reported visual difficulty.Materials and MethodsWe applied the Bradford Hill criteria to evaluate the case for a bidirectional causal relationship between vision-related anxiety and self-reported visual difficulty.ResultsThere is sufficient evidence to satisfy all nine of the Bradford Hill criteria of causality (strength of association, consistency, biological gradient, temporality, experimental evidence, analogy, specificity, plausibility, and coherence) for the relationship between vision-related anxiety and self-reported visual difficulty.ConclusionsThe evidence suggests that there is a direct positive feedback loop-a bidirectional causal relationship-between vision-related anxiety and self-reported visual difficulty. More longitudinal research on the relationship between objectively-measured vision impairment, self-reported visual difficulty, and vision-related psychological distress is needed. Additionally, more investigation of potential interventions for vision-related anxiety and visual difficulty is needed.
Palavras-chave
Anxiety, disability, quality of life, low vision
Referências
- Akuffo KO, 2021, BMC PSYCHOL, V9, DOI 10.1186/s40359-021-00558-x
- Assi L, 2021, JAMA OPHTHALMOL, V139, P526, DOI 10.1001/jamaophthalmol.2021.0146
- Bitar MS, 2019, CORNEA, V38, P684, DOI 10.1097/ICO.0000000000001932
- Blanco C, 2014, DEPRESS ANXIETY, V31, P756, DOI 10.1002/da.22247
- Brenes GA, 2005, J AM GERIATR SOC, V53, P34, DOI 10.1111/j.1532-5415.2005.53007.x
- Caballe-Fontanet D, 2022, INT J ENV RES PUB HE, V19, DOI 10.3390/ijerph19020820
- Carriere I, 2013, J AFFECT DISORDERS, V151, P164, DOI 10.1016/j.jad.2013.05.071
- Choi S, 2018, JAMA OPHTHALMOL, V136, P1432
- Choi S, 2018, JAMA OPHTHALMOL, V136, P1399, DOI 10.1001/jamaophthalmol.2018.3892
- Clancy F, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhurn.2016.00534
- Cosh S, 2018, INT J GERIATR PSYCH, V33, P598, DOI 10.1002/gps.4827
- D'Amanda CS, 2020, SURV OPHTHALMOL, V65, P562, DOI 10.1016/j.survophthal.2020.02.002
- DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101
- Diniz A, 2016, OPHTHALMOLOGY, V123, P754, DOI 10.1016/j.ophtha.2015.12.014
- Fedak KM, 2015, EMERG THEMES EPIDEMI, V12, DOI 10.1186/s12982-015-0037-4
- Frank CR, 2019, JAMA OPHTHALMOL, V137, P793, DOI 10.1001/jamaophthalmol.2019.1085
- Garip G, 2019, BMC OPHTHALMOL, V19, DOI 10.1186/s12886-019-1169-z
- Genovese G, 2021, MEDICINA-LITHUANIA, V57, DOI 10.3390/medicina57060628
- Georgiou M, 2021, CLIN EXP OPHTHALMOL, V49, P270, DOI 10.1111/ceo.13917
- Goldstein JE, 2014, JAMA OPHTHALMOL, V132, P1169, DOI 10.1001/jamaophthalmol.2014.1747
- Goldstein JE, 2012, ARCH OPHTHALMOL-CHIC, V130, P1028, DOI 10.1001/archophthalmol.2012.1197
- Guidi J, 2020, PSYCHOTHER PSYCHOSOM, V90, P11, DOI 10.1159/000510696
- Guo Xinxing, 2023, JAMA Netw Open, V6, pe2254006, DOI 10.1001/jamanetworkopen.2022.54006
- Heesterbeek TJ, 2017, OPHTHAL PHYSL OPT, V37, P385, DOI 10.1111/opo.12388
- Hendriks SM, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0946-y
- HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
- Horowitz A, 2005, AGING MENT HEALTH, V9, P563, DOI 10.1080/13607860500193500
- Horowitz A, 2006, J GERONTOL B-PSYCHOL, V61, pS274, DOI 10.1093/geronb/61.5.S274
- Hyon J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40539-0
- Jack K, 2010, MANUAL THER, V15, P220, DOI 10.1016/j.math.2009.12.004
- Jackson JS, 2010, AM J PUBLIC HEALTH, V100, P933, DOI 10.2105/AJPH.2008.143446
- Kempen GIJM, 2014, AM J GERIAT PSYCHIAT, V22, P309, DOI 10.1016/j.jagp.2012.08.007
- Kempen GIJM, 2012, QUAL LIFE RES, V21, P1405, DOI 10.1007/s11136-011-0061-y
- Kong XM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004632
- Lacy GD, 2020, OPHTHALMIC GENET, V41, P315, DOI 10.1080/13816810.2020.1776337
- Lam BL, 2008, ARCH OPHTHALMOL-CHIC, V126, P975, DOI 10.1001/archopht.126.7.975
- Lamoureux EL, 2007, INVEST OPHTH VIS SCI, V48, P1001, DOI 10.1167/iovs.06-0361
- Lim MC, 2013, J GLAUCOMA, V22, P439, DOI 10.1097/IJG.0b013e31824cd0ae
- Lundeen EA, 2022, OPHTHAL EPIDEMIOL, V29, P171, DOI 10.1080/09286586.2021.1918177
- Mangione CM, 1998, ARCH OPHTHALMOL-CHIC, V116, P227
- Margolis MK, 2002, PHARMACOECONOMICS, V20, P791, DOI 10.2165/00019053-200220120-00001
- McEwen Bruce S, 2017, Chronic Stress (Thousand Oaks), V1, DOI 10.1177/2470547017692328
- McEwen BS, 2011, ANNU REV MED, V62, P431, DOI 10.1146/annurev-med-052209-100430
- McGrady A, 2009, J CARDIOPULM REHABIL, V29, P358, DOI 10.1097/HCR.0b013e3181be7a8f
- Mennin DS, 2013, CLIN PSYCHOL-SCI PR, V20, P258, DOI 10.1111/cpsp.12038
- Nollett C, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026163
- Nuzbrokh Y, 2021, ANN TRANSL MED, V9, DOI 10.21037/atm-20-4726
- Office of Disease Prevention and Health Promotion Office of the Assistant Secretary for Health, INCR US VIS REH SERV
- Ottaviani C, 2016, PSYCHOL BULL, V142, P231, DOI 10.1037/bul0000036
- Owsley C, 2019, JAMA OPHTHALMOL, V137, P801, DOI 10.1001/jamaophthalmol.2019.1084
- Owsley C, 2009, ARCH OPHTHALMOL-CHIC, V127, P681, DOI 10.1001/archophthalmol.2009.55
- Popova LT, 2023, OPHTHALMIC GENET, V44, P11, DOI 10.1080/13816810.2022.2144901
- Rees G, 2010, INVEST OPHTH VIS SCI, V51, P2891, DOI 10.1167/iovs.09-5080
- Robinson ME, 2004, PAIN MED, V5, P66, DOI 10.1111/j.1526-4637.2004.04002.x
- Sahel JA, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a017111
- Salman M, 2020, AM J OPHTHALMOL, V216, P207, DOI 10.1016/j.ajo.2020.02.009
- Sekimitsu Sayuri, 2022, Can J Ophthalmol, DOI 10.1016/j.jcjo.2022.11.019
- Senra H, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-06252-1
- Shah K, 2020, EYE, V34, P290, DOI 10.1038/s41433-019-0712-8
- SHMUELYDULITZKI Y, 1995, AM J GERIAT PSYCHIAT, V3, P325, DOI 10.1097/00019442-199503040-00007
- Sims M, 2016, J EPIDEMIOL COMMUN H, V70, P187, DOI 10.1136/jech-2015-206390
- Stringham J, 2018, EYE CONTACT LENS, V44, P50, DOI 10.1097/ICL.0000000000000301
- Swamy BN, 2009, ACTA OPHTHALMOL, V87, P335, DOI 10.1111/j.1755-3768.2008.01203.x
- Tseng YC, 2018, QUAL LIFE RES, V27, P1957, DOI 10.1007/s11136-018-1799-2
- Ustun B, 2009, WORLD PSYCHIATRY, V8, P82
- Ulhaq ZS, 2022, THER ADV OPHTHALMOL, V14, DOI 10.1177/25158414221090100
- van der Aa HPA, 2016, OPHTHAL PHYSL OPT, V36, P584, DOI 10.1111/opo.12313
- van der Aa HPA, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6127
- van der Aa HPA, 2015, INVEST OPHTH VIS SCI, V56, P849, DOI 10.1167/iovs.14-15848
- van der Aa HP., 2016, BMJ-BRIT MED J, V353, pi1995
- van Nispen RMA, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006543.pub2
- Wang MR, 2021, EXP EYE RES, V213, DOI 10.1016/j.exer.2021.108853
- Wu N, 2022, BMJ OPEN, V12, DOI 10.1136/bmjopen-2020-046194